News from the FDA/CDC

News

Selinexor hits FDA stumbling block

The Oncologic Drugs Advisory Committee expressed concern about the high rate of serious adverse events with the drug being developed to treat...

News

FDA approves caplacizumab for aTTP

The injection is approved in combination with plasma exchange and immunosuppressive therapy for adults with acquired thrombotic thrombocytopenia...

Pages